参考文献 References
[1] 陈典,隆寰宇,李姝润,等.2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J].中国全科医学,2024,27(13):1533-1543,1567.
[2] Adeloye D,et al.Research priorities to address the global burden of chronic obstructive pulmonary disease(COPD)in the next decade[J].J Glob Health,2021, 11:15003.
[3] Boers E,et al.Global burden of chronic obstructive pulmonary disease through 2050[J].JAMA Netw Open, 2023, 6(12):e2346598.
[4] Zhou Z,et al.Chronic obstructive pulmonary disease-associated mortality—China, 2014–2021[J]. China CDC Weekly,2024,6(43):1105-1110.
[5] 医疗应急司.关于印发健康中国行动——慢性呼吸系统疾病防治行动实施方案（2024—2030年）的通知[Z].2024.
[6] 国家卫生健康委员会基层司.关于做好2024年基本公共卫生服务工作的通知[Z].2024.
[7] Jansen E M,et al.Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers[J]. J Thorac Dis,2021, 13(6):3846-3864.
[8] Vauterin D,et al.Medication adherence to inhalation therapy and the risk of COPD exacerbations:a systematic review with meta-analysis[J].BMJ Open Respir Res,2024,11: e001964.
[9] George M.Adherence in asthma and COPD:new strategies for an old problem[J]. Respir Care,2018,63(6):818-831.
[10] Chan A H Y, et al. Digital inhalers for asthma or chronic obstructive pulmonary disease:a scientific perspective[J]. Pulm Ther,2021,7(2):345-376.
[11] Levy M L,et al.Uncovering patterns of inhaler technique and reliever use:the value of objective,personalized data from a digital inhaler[J].NPJ Prim Care Respir Med, 2024,34:23.
[12] Aung H,et al.Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis[J].Eur Respir Rev,2024,33(174):240136.
[13] Crooks M G,et al.Evidence generation for the clinical impact of myCOPD in patients with mild,moderate,and newly diagnosed COPD:a randomised controlled trial[J]. ERJ Open Res,2020,6(4):00460-2020.
[14] North M,et al.A randomised controlled feasibility trial of e-health application supported care vs usual care after exacerbation of COPD:the RESCUE trial[J].NPJ Digit Med,2020,3:145.
[15] Gelbman B D,et al.An integrated,multimodal,digital health solution for chronic obstructive pulmonary disease: prospective observational pilot study[J].JMIR Form Res, 2022,6(3):e34758.
[16] Kaye L,et al.The relationship between objective app engagement and medication adherence in asthma and COPD:a retrospective analysis[J].Sci Rep,2021,11:24343.
[17] Plaza V,et al.Validation of the Test of the Adherence to Inhalers (TAI)for asthma and COPD patients[J].J Aerosol Med Pulm Drug Deliv,2016,29(2):142-152.
[18] 孟文文,等.慢性呼吸系统疾病相关研究[J].中华结核和呼吸杂志,2022, 45(5):423-430.
[19] Morisky D E,Green L W,Levine D M.Concurrent and predictive validity of a self-reported measure of medication adherence[J].Med Care,1986,24(1):67-74.
[20] Morisky D E,et al.Predictive validity of a self-reported measure of medication adherence:The Morisky Medication Adherence Scale[J].Med Care,2008,46(6):512-518.
[21] 王肖芹,卢玉林,史书毓,等.慢阻肺患者用药依从性预测评估量表的编制及应用[J].中南药学,2024,22(10):2780-2786.
[22] Poletti V,Pagnini F,Banfi P,Volpato E.Illness perceptions, cognitions, and beliefs on COPD patients' adherence to treatment–a systematic review[J]. Patient Prefer Adherence, 2023,17:1845-1866.
[23] Montes de Oca M,et al.Adherence to inhaled therapies of COPD patients from seven Latin American countries:The LASSYC study[J].PLoS One,2017,12(11):e0186777.
[24] Liu Y R,et al.Association between illness perception and adherence to inhaler therapy in elderly Chinese COPD patients[J].Chronic Respiratory Disease,2024, 21:1479973 1241286837.
[25] Peng Y,et al.Adherence to inhaled therapy in COPD associated with pneumoconiosis[J].Int J Chron Obstruct Pulmon Dis,2021,16:2697-2706.
[26] Zhang M,Tang T, Wan M,et al.Self-reported reasons for treatment nonadherence in COPD patients:a 24-week prospective cohort study[J].Ann Palliat Med, 2020, 9(5): 3495-3505.
[27] Aldan G,et al.Multidimensional factors affecting medication adherence in COPD[J].J Clin Nurs,2022,31(9-10):1202-1215.
[28] O’Toole J,Krishnan M,Riekert K,Eakin M N. Barriers and strategies for medication adherence in COPD:a qualitative study[J].BMC Pulm Med,2022,22:98.
[29] Poletti V,Pagnini F,Banfi P,Volpato E.Illness perceptions and COPD adherence–systematic review[J].Patient Prefer Adherence,2023,17:1845-1866.
[30] Zheng L,et al.Factors influencing inhalation adherence in COPD patients[J].J Eval Clin Pract,2024:e14094.
[31] Adisa R,et al.Pharmacist-led intervention in COPD adherence and inhaler usage[J].BMC Health Serv Res, 2024,24:1199.
[32] Sarwar M R,et al.Pharmacist-led home medicines review in COPD[J].Int J Clin Pharm,2024.
[33] Criner G J,et al.Budesonide/Formoterol medication reminders and adherence in COPD:randomized study[J].Int J Chron Obstruct Pulmon Dis,2021,16:563-577.
[34] 邵国娟.个体化健康教育模式对慢阻肺患者依从性的影响[J].实用临床护理学电子杂志, 2020,5(21):186,194.
[35] 李丽丽.慢阻肺吸入治疗依从性影响因素[J].现代医学与健康研究电子杂志,2021, 5(5):140-142.
[36] Aung H,et al.Digital inhaler interventions in COPD: systematic review[J].Eur Respir Rev,2024,33(174):240136.
[37] 刘建萍.循证护理对慢阻肺患者依从性及肺功能影响[J].临床医药文献电子杂志,2020, 7(49):7,24.
[38] 方香香.循证护理对慢阻肺治疗依从性及肺功能影响[J].临床研究,2020, 28(5):177-178.